William K Hagmann

This inventor holds 77 USPTO granted patents and 4 published patent applications and 10 EPO patents, primarily in Antidiabetic Compounds (CPC class A61K). Top assignees: Merck + Co., Inc., Merck Sharp + Dohme Corp.. Active years: 1986-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William K Hagmann. Retrieved from https://idiyas.com/inventor/william-k-hagmann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 77 (Patent Applications = 4)

% Patents Active = 79.2

EPO Patents = 10 (Patent Applications = 7)

Average Co-Inventor Count = 4.3

ph-index = 16

Forward Citations = 734(Granted Patents)

Forward Citations (Not Self Cited) = 692(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Rahway, NJ (US) (1999)
Westfield, PA (US) (2010)
Westfield, NJ (US) (1986 - 2018)

Company Filing History:

Merck Sharp + Dohme Corp.

patents

Years Active: 1986-2018

Loading Chart...

Areas of Expertise:

Antidiabetic Compounds

Cell Adhesion Inhibitors

Metallo-Beta-Lactamase Inhibitors

Tricyclic Compounds

Bicyclic Compounds

Heteroaryl Compounds

Amides

Aza-Bicyclic Derivatives

Nitric Oxide Synthase Inhibitors

Cyclic Amino Acid Derivatives

Sulfonamide Derivatives

Biarylalkanoic Acids

77 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10000454 - Antidiabetic tricyclic compounds (2018-06-19),

2. 9932311 - Antidiabetic tricyclic compounds (2018-04-03),

3. 9840512 - Antidiabetic bicyclic compounds (2017-12-12),

4. 9839642 - Beta-tetrazolyl-propionic acids as metallo-beta-lactamase inhibitors (2017-12-12),

5. 9834563 - Antidiabetic substituted heteroaryl compounds (2017-12-05),

6. 9708336 - Metallo-beta-lactamase inhibitors (2017-07-18),

7. 9527875 - Antidiabetic tricyclic compounds (2016-12-27),

8. 8754099 - Oxadiazole beta carboline derivatives as antidiabetic compounds (2014-06-17),

9. 7816534 - Substituted amides (2010-10-19),

10. 7754188 - Radiolabeled cannabinoid-1 receptor modulators (2010-07-13),

11. 7667053 - Bicyclic amides (2010-02-23),

12. 7576239 - Substituted amides (2009-08-18),

13. 7550489 - Substituted pyridyoxy amides (2009-06-23),

14. 7514409 - VLA-4 antagonists (2009-04-07),

15. 7423067 - Diphenyl cyclopentyl amides as cannabinoid-1 receptor inverse agonists (2008-09-09),

Title: William K Hagmann - Innovative Inventor from Westfield, NJ

Introduction: William K Hagmann is a renowned inventor hailing from Westfield, NJ, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: William K Hagmann holds several patents in the areas of technology, healthcare, and consumer products, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, William K Hagmann has established himself as a prolific inventor with a keen eye for identifying gaps in the market and developing unique solutions to address them. His inventions have not only improved efficiency in various industries but have also enhanced the quality of life for many individuals.

Collaborations: Throughout his career, William K Hagmann has collaborated with leading companies, research institutions, and universities to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: William K Hagmann's passion for innovation and his relentless drive to push the boundaries of what is possible make him a standout figure in the world of inventors. His contributions have left a lasting impact on society and continue to inspire future generations of inventors.

Profile summary based on public USPTO records.